54 high-performance-computing-postdoc Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
across the spectrum of fibre laser development, from the development of new fibre core materials, to addressing limits imposed by instabilities, noise and nonlinearities, to high-speed beam and
-
(UTC) Country United Kingdom Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
16 Mar 2026 Job Information Organisation/Company UNIVERSITY OF SOUTHAMPTON Research Field Computer science Engineering Researcher Profile First Stage Researcher (R1) Application Deadline 10 Apr 2026
-
16 Mar 2026 Job Information Organisation/Company UNIVERSITY OF SOUTHAMPTON Research Field Biological sciences Computer science Engineering Chemistry Researcher Profile First Stage Researcher (R1
-
and Political Parties in Europe (DISPOP). Despite reporting high levels of interest in electoral politics, disabled people have lower voter turnout rates and are under-represented in legislatures around
-
by building new AI tools that can work alongside human analysts. Intelligence analysts are routinely required to make high-consequence, defensible assessments from vast, complex and uncertain datasets
-
biggest challenges. We are seeking a Research Fellow in Liquid Metal Artificial Enzymes to join the School of Electronics and Computer Science (ECS) at the University of Southampton. The successful
-
Apr 2026 - 00:00 (UTC) Country United Kingdom Type of Contract Other Job Status Part-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related
-
. Deliver high-quality measurements of plant physiology and growth under defined environmental and acoustic conditions. Lead below-ground sampling and analyses, including root phenotyping/architecture
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic